drugset / Trial / NCT04397341

Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck

NCT04397341 ↗

Phase 2 Completed 58 enrolled China Medical University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study aimed to assess the efficacy and safety for biweekly TPF as induction chemotherapy for locally advanced head and neck cancer

Timeline

Start
2014-03-01
Primary completion
2016-08-30
Completion
2019-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 50 mg/m2 —
Subject Docetaxel Small molecule 50 mg/m2 —
Subject fluorouracil Small molecule 2500 mg/m2 —